Filgrastim biosimilar - Profarma

Drug Profile

Filgrastim biosimilar - Profarma

Alternative Names: PF-07

Latest Information Update: 15 Jun 2015

Price : $50

At a glance

  • Originator Profarma
  • Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants
  • Mechanism of Action Granulocyte colony stimulating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 15 Jun 2015 Preclinical trials in Cancer in Lithuania (unspecified route) (Profarma pipeline, June 2015)
  • 02 Apr 2015 Profarma has patent protection for filgrastim biosimilar (Profarma website, June 2015) before April 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top